E014 Hypertrophy of the cerebral parasagittal dural space, an emerging neurofluid egress conduit, relates to disease severity in Huntington disease
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background/Aims Aberrant cerebrospinal fluid (CSF) flow and egress persist in many patients with Huntington’s disease (HD), and quantitation of these phenomena could inform mechanisms of disease progression and potentially assist with triaging patients for intrathecally-administered therapies. This work reports on the relevance of a recently-identified parasagittal dural (PSD) CSF egress pathway, using magnetic resonance imaging, to symptomatology across the spectrum of HD severity. Methods PSD was quantified using a recently-validated T2-weighted MRI and associated deep-learning segmentation in genetic-expanded (GE; n=57) and age-matched gene non-expanded (GNE; n=54) carriers. GE carriers were stratified by disease stage per HD-ISS criteria. CAP score and UHDRS total motor scores (TMS) were used to characterize disease burden and clinical symptom severity, respectively. Linear regression models and Spearman correlation were applied to assess GNE and GE-stage group-wise differences with PSD, and PSD relationship with disease burden, symptomatology, and relevant co-variates (significance criterion: p<0.05). Results A significant increase of PSD volume in GE versus GNE carriers, in early (HD-ISS stages=0–1; p=0.046) and later (HD-ISS stages=2–3; p=0.019) stage was observed. PSD hypertrophy relates directly to CAP score (p=0.002) and TMS (p=0.001). These relationships were confirmed with linear regression models after controlling for age, sex, and intracranial volume. Conclusions PSD, a structure with emerging relevance to neurofluid egress and proteinopathy, directly relates to HD disease stage, burden, and clinical severity. Disease modification treatment trials, especially antisense oligomer trials, may interpret immune processes and treatment efficacy across the spectrum of diverse neurofluid kinetics within conventional and more novel PSD channels.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- E014 Hypertrophy of the cerebral parasagittal dural space, an emerging neurofluid egress conduit, relates to disease severity in Huntington disease
- Date Crossref
- 01/09/2024
- Éditeur
- BMJ Publishing Group Ltd
- Type
- proceedings-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Vanderbilt University Medical Center Dept. of Neurology pays non établi dans la noticeÉtablissement de santé
-
Vanderbilt University pays non établi dans la noticeUniversité ou école supérieure
Dept. of Neurology — Vanderbilt University Medical Center et Vanderbilt University.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.